Montchanin Asset Management, LLC Durect Corp Call Options Transaction History

Montchanin Asset Management, LLC

  • $106 Million
  • Q2 2024

Call Options

0 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
No transaction found.

Others Institutions Holding DRRX

# of Institutions
3
Shares Held
591K
Call Options Held
0
Put Options Held
0
View Full List

About DURECT CORP

DRRX Quotes by TradingView
  • Ticker DRRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 227,794,000
  • Market Cap $301M
  • Description
  • DURECT Corporation, a biopharmaceutical company, researches and develops medicines based on its epigenetic regulator and pharmaceutical programs. The company offers ALZET product line that consists of osmotic pumps and accessories used for research in mice, rats, and other laboratory animals. It also develops larsucosterol (DUR-928), an endogeno...
More about DRRX
Track This Portfolio

Track Montchanin Asset Management, LLC Portfolio

Follow Montchanin Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Montchanin Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Montchanin Asset Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email